Article Details

Pfizer, BioNTech Conclude Phase III COVID-19 Vax Study

Retrieved on: 2020-11-17 23:18:20

Tags for this article:

Click the tags to see associated articles and topics

Pfizer, BioNTech Conclude Phase III COVID-19 Vax Study. View article details on hiswai:

Excerpt

<div>Pfizer and <b>BioNTech</b> SE conducted the final efficacy analysis in their ongoing Phase III study, their mRNA-based COVID-19 vaccine candidate, ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up